难治性瘢痕疙瘩的治疗进展

姚红霞; 张金山

doi:10.3760/cma.j.issn.1673-4114.2009.04.014

难治性瘢痕疙瘩的治疗进展

姚红霞 , 张金山

文章导航 > 国际放射医学核医学杂志 > 2009, 33 > 4: (237-239)

引用本文:

Citation:

难治性瘢痕疙瘩的治疗进展

姚红霞^,,
张金山

广州医学院第三附属医院核医学科, 广州, 510050

通讯作者: 姚红霞, hx_yao@21cn.com ;

The advance in the therapy of therapy-resistant keloids

YAO Hong-xia^,,
ZHANG Jin-shan

Department of Nuclear Medicine, the Third Affiliated Hospital of Guangzhou Medical College, Guangzhou 510050, China

Corresponding author: YAO Hong-xia, hx_yao@21cn.com ;

摘要: 瘢痕疙瘩是一种良性真皮肿瘤,难治性瘢痕疙瘩包括经病灶手术切除联合X线外放疗、药物治疗、局部注射皮质激素或钙离子阻滞剂、硅凝胶治疗、物理治疗等无效或复发的瘢痕疙瘩,这种不能行上述治疗的或合并感染的瘢痕,治疗困难、复发率高。应用³²P及辅助一定浓度的维生素E对难治性瘢痕疙瘩的治疗可能有潜在的重要作用。
- 瘢痕疙瘩 /
- 维生素E /
- 磷放射性同位素
Abstract: Keloids are huamn benign dermal tumors, excessive fibroproliferative disorders that enlarge and extend beyond the margins of the origin wounds. Some keloids have proven to be very resistant to treatment, for example, several treatment modalities including surgical excision in combination with radiotherapy in the form of roentgen radiation (X-ray), pharmaceuticals, intralesional corticosteroids or calcium ions blocking agents, silicone gel sheets, physical therapy such as pressuretherapy, lasertherapy, cryotherpay might be less efficacious, and sometimes they cannot be performed because of limited conditions.Some keloids have higher recurrence rates. It is difficult to treat some keloids with complications of infection,³²p-phosphours combination with vittamin E may be iuseful to treat therapy-resistant keloids.
- Keloids /
- Vitamin E /
- Phosphorus radioisotopes
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Zurada JM,Kriegel D,Davis IC.Topical treatments for hypertrophic scars.J Am Acad Dermatol,2006,55(6):1024-1031.
[2]	Chen MA,Davidson TM.Scar management:prevention and treatment strategies.Curr Opin Otolaryngol Head Neck Surg,2005,13(4):242-247.
[3]	Poochareon VN,Berman B.New therapies for the management of keloids,J Craniofac Surg,2003,14(5):654-657.
[4]	Jones K,Fuller CD,Luh JY,et al.Case report and summary of literature:giant perineal keloids treated with post-excisional radiotherapy.BMC Dermatol,2006,6:7.
[5]	Dinh Q,Veness M,Richards S.Role of adjuvant radiotherapy in recurrent earlobe keloids.Australas J Dermatol,2004,45(3):162-166.
[6]	Palmieri B,Gozzi G,Palmieri G.Vitamin E added silicone gel sheets for treatment of hypertrophic scars and keloids.Int J Dermatol,1995,34(7):506-509.
[7]	付小兵,程越.病理性瘢痕治疗现状与展望.中华整形外科杂志,2006,22(2):146-149.
[8]	周显青,孙儒泳,牛翠娟.维生素E对免疫功能的影响.生理科学进展,2000,31(2):163-165.
[9]	Yano T,Yajima S,Hagiwara K, et al.Vitamin E inhibits cell proliferation and the activation of extracellular signal-regulated kinase during the promotion phase of lung tumorigenesis irrespective of antioxidalive effect.Carcinogenesis,2000,21(IV):2129-2133.
[10]	Lawson KA,Anderson K,Simmons-Menchaca M,et al.Comparison of vitamin E derivatives alpha-TEA and VES in reduction of mouse mammary tumor burden and metastasis.Exp Biol Med (Maywood),2004,229(9):954-963.
[11]	Venkateswaran V,Fleshner NE,Klotz LH.Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines.J Urol,2002,168(4Ptl):1578-1582.
[12]	Zhan Y,Wang Y,Wei L,et al.Effects of vitamin E on the proliferation and collagen synthesis of rat hepatic stellate cells treated with IL-2 or TNF-alpha.Chin Med J (Engl),2003,116(3):472-474.
[13]	Zhang Y,Yasumoto Y,Mei C,et al.Vitamin E inhibits proliferation of primary cultured human mesangial and endothelialcells.Nephron,2001,89(3):291-296.
[14]	Baumann LS,Spencer J.The effects of topical vitamin E on the cosmetic appearance of scars.Dermatol Surg,1999,25(4):311-315.
[15]	van de Kar AL,Kreulen M,van Zuijlen PP,et al.The results of surgical excision and adjuvant irradiation for therapy-resistantkeloids:a prospective clinical outcome study,Plast Reconstr Surg,2007,119(7):2248-2254.

[1]	贺特 , 马云 , 王五洲 , 贺俊彦 , 蒋雨薇 , 曹旭琴 , 何淑雅 . 维生素 E对果蝇辐射氧化损伤机制的影响. 国际放射医学核医学杂志, 2019, 43(3): 257-262. doi: 10.3760/cma.j.issn.1673-4114.2019.03.010
[2]	陈越虹 , 陆勤 , 黄忆云 , 罗全勇 , 沈晨天 . 硅胶片对⁹⁰Sr-⁹⁰Y敷贴治疗瘢痕疙瘩中放射性皮炎预防作用的研究. 国际放射医学核医学杂志, 2023, 47(9): 538-544. doi: 10.3760/cma.j.cn121381-202209009-00334
[3]	姚立新 , 刘彬彬 , 刘连元 . ⁹⁰Sr敷贴器一次性大剂量治疗瘢痕疙瘩疗效评价. 国际放射医学核医学杂志, 2005, 29(6): 267-268.
[4]	洪敏 , 张帅君 , 余道江 , 张舒羽 . 术后放疗在瘢痕疙瘩治疗中的研究进展. 国际放射医学核医学杂志, 2021, 45(3): 198-204. doi: 10.3760/cma.j.cn121381-202007019-00029
[5]	苏文星 , 黄彪 , 张舒羽 , 余道江 . 近距离放疗在瘢痕疙瘩治疗中的研究进展. 国际放射医学核医学杂志, 2023, 47(9): 579-583. doi: 10.3760/cma.j.cn121381-202206011-00337
[6]	计学理 , 王胜利 , 杨靖 , 肖来华 , 耿建 , 赵晓字 , 刘建功 . ³²P-胶体灌注治疗慢性上颌窦炎动物模型的实验研究计学理. 国际放射医学核医学杂志, 2006, 30(4): 206-209.
[7]	范仰钢 , 胡尊玲 , 袁国强 . ³²P-磷酸铬胶体滑膜切除术联合常规药物治疗强直性脊柱炎髋关节病变. 国际放射医学核医学杂志, 2011, 35(5): 285-288. doi: 10.3760/cma.j.issn.1673-4114.2011.05.008
[8]	施常备 , 许建林 , 袁勇 , 陆建荣 , 袁彬 , 赵明刚 , 王翔 , 陈葳 , 邓敬兰 . 染色体畸变率估算³²P的辐射剂量. 国际放射医学核医学杂志, 2012, 36(1): 35-37. doi: 10.3760/cma.j.issn.1673-4114.2012.01.009
[9]	农天雷 . ³²P胶体内照射治疗海绵状血管瘤疗效分析. 国际放射医学核医学杂志, 2010, 34(3): 177-178. doi: 10.3760/cma.j.issn.1673-4114.2010.03.014
[10]	刘永昌 , 林祥通 , 沈家立 . 放射性同位素在肾移植中的应用及其进展. 国际放射医学核医学杂志, 1977, 1(2): 1-8.
[11]	朱国泓 . 放射性同位素测定肺分区功能. 国际放射医学核医学杂志, 1977, 1(2): 8-12.
[12]	周月霞 , 董填安 , 江一民 , 袁家齐 , 赵惠扬 . 冻结病的放射性同位素扫描. 国际放射医学核医学杂志, 1982, 6(1): 66-66.

点击查看大图

计量

文章访问数: 1681
HTML全文浏览量: 141
PDF下载量: 5

难治性瘢痕疙瘩的治疗进展

姚红霞^,
张金山

通讯作者: 姚红霞, hx_yao@21cn.com;

广州医学院第三附属医院核医学科, 广州, 510050

收稿日期: 2009-01-28

关键词:

摘要: 瘢痕疙瘩是一种良性真皮肿瘤,难治性瘢痕疙瘩包括经病灶手术切除联合X线外放疗、药物治疗、局部注射皮质激素或钙离子阻滞剂、硅凝胶治疗、物理治疗等无效或复发的瘢痕疙瘩,这种不能行上述治疗的或合并感染的瘢痕,治疗困难、复发率高。应用³²P及辅助一定浓度的维生素E对难治性瘢痕疙瘩的治疗可能有潜在的重要作用。